Dr. Leandro Cerchietti has received a Doris Duke Clinical Scientist Development Award (one of only 12 such awards given yearly by the Doris Duke Foundation). Funding is $150,000 per year spanning 3 years; his project centers on the role of metabolism in determining the clinical behavior of tumors, using metabolomic profiling for the study of B-cell lymphoma.
Dr. Gail J. Roboz is physician to ABC Good Morning America anchor Robin Roberts. She treated Ms. Roberts who has MDS, or myelodysplastic syndrome, a disorder of the stem cells in bone marrow that impairs blood production.
The 2012 Department of Medicine Investigator Award finalists were announced and their talks were delivered during Grand Rounds on May 22, 2012. This was the 21st annual presentation of the DOM Investigator Award, which is presented to members of the Department of Medicine, below the rank of professor, who perform on an outstanding level in the areas of clinical and/or basic biomedical research. The award is generously supported by the Michael Wolk Foundation.
Dr. Ari Melnick and colleagues have received a multi-investigator collaborative grant from the National Cancer Institute in support of clinical trials for the treatment of cancer; this, following their most recent discovery involving a tumor-targeting compound known as PU-H71, which was published in Nature Chemical Biology.
The paper published in Cancer Discovery identifies a new molecular target for this lethal subtype of prostate cancer for which there is currently a drug available. Specifically, Drs. Beltran and Rubin have discovered that the aurora kinase inhibitor PHA-739358 works against human neuroendocrine prostate cells.
Located on Floor 12 of the Weill Greenberg Ambulatory Building, 1305 York Avenue, the stunningly attractive facilities represent state-of-the-art patient care at its best. Individual treatment bays are equipped with flat screen televisions and provide sweeping views of York Avenue.
Dr. Richard T. Silver was an invited lecturer at the "Leukemia and Lymphoma: East and West are Together" Conference sponsored by the M.D. Anderson Cancer Center, held in Dubrovnik, Croatia from September 16-21. He spoke about the treatment of polycythemia vera with interferon.
Dr. Manish Shah has pursued a career in Medical Oncology with a primary focus on clinical translational medicine in GI Oncology that melds his research experience at the bench with patient care.
A molecular trigger involved in lung regeneration has been uncovered. Investigators – including Dr. Ronald G. Crystal (Chief of Pulmonary and Critical Care Medicine) and Dr. Shahin Rafii (Professor of Medicine/Medicine & Genetics) – have published their findings in Cell. The discovery is part of a labyrinth of advances toward a fuller understanding of the process of lung regeneration.
Beloved by patients, colleagues, and friends alike, Dr. Anne Moore has long been recognized for her pioneering career and her devotion to patient care in the field of breast cancer. She was honored on June 1, 2011 with the Maurice R. Greenberg Distinguished Service Award.
